Computerized detection of adverse drug reactions in the medical intensive care unit. 2011

Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
Department of Pharmacy and Therapeutics, School of Pharmacy, University Pittsburgh, Pittsburgh, PA 15261, United States. Slk54@pitt.edu

OBJECTIVE Clinical event monitors are a type of active medication monitoring system that can use signals to alert clinicians to possible adverse drug reactions. The primary goal was to evaluate the positive predictive values of select signals used to automate the detection of ADRs in the medical intensive care unit. METHODS This is a prospective, case series of adult patients in the medical intensive care unit during a six-week period who had one of five signals presents: an elevated blood urea nitrogen, vancomycin, or quinidine concentration, or a low sodium or glucose concentration. Alerts were assessed using 3 objective published adverse drug reaction determination instruments. An event was considered an adverse drug reaction when 2 out of 3 instruments had agreement of possible, probable or definite. Positive predictive values were calculated as the proportion of alerts that occurred, divided by the number of times that alerts occurred and adverse drug reactions were confirmed. RESULTS 145 patients were eligible for evaluation. For the 48 patients (50% male) having an alert, the mean±SD age was 62±19 years. A total of 253 alerts were generated. Positive predictive values were 1.0, 0.55, 0.38 and 0.33 for vancomycin, glucose, sodium, and blood urea nitrogen, respectively. A quinidine alert was not generated during the evaluation. CONCLUSIONS Computerized clinical event monitoring systems should be considered when developing methods to detect adverse drug reactions as part of intensive care unit patient safety surveillance systems, since they can automate the detection of these events using signals that have good performance characteristics by processing commonly available laboratory and medication information.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D010414 Pennsylvania State bounded on the north by New York and Lake Erie, on the east by Delaware and New Jersey, on the south by Delaware and Maryland, and on the west by Ohio and West Virginia.
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
July 2009, Pharmacoepidemiology and drug safety,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
August 2023, Current drug safety,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
August 2009, Pharmacoepidemiology and drug safety,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
September 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
April 1995, Acta paediatrica (Oslo, Norway : 1992),
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
January 2012, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
August 2021, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
June 2010, Critical care medicine,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
June 2010, Critical care medicine,
Sandra L Kane-Gill, and Shyam Visweswaran, and Melissa I Saul, and An-Kwok Ian Wong, and Louis E Penrod, and Steven M Handler
January 2013, European journal of clinical pharmacology,
Copied contents to your clipboard!